David Toung Analyst PerformanceSenior Analyst at ArgusDavid Toung is a stock analyst at Argus focused in the medical sector, covering 23 publicly traded companies. Over the past year, David Toung has issued 15 stock ratings, including buy and hold recommendations. While full access to David Toung's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights David Toung's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings47 Last 11 YearsBuy Recommendations84.09% 37 Buy RatingsCompanies Covered23 Unique Companies Ratings Distribution44RatingsDistribution of strong buy, buy, hold, and sell ratings by David Toung.RatingPercentageCount Strong Buy0.0%0 ratings Buy84.1%37 ratings Hold15.9%7 ratings Sell0.0%0 ratingsOut of 44 total stock ratings issued by David Toung at Argus, the majority (84.1%) have been Buy recommendations, followed by 15.9% Hold.Best & Worst CallsBest Call000.0%MCKNov 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%IARTMar 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE78.3% of companies on NYSE18 companiesNASDAQ21.7% of companies on NASDAQ5 companiesDavid Toung, an analyst at Argus, currently covers 23 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageMedical22 companies95.7%Computer and Technology1 company4.3%David Toung of Argus specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology companies.Coverage IndustriesIndustryPercentageMED PRODUCTS5 companies21.7%MED INSTRUMENTS3 companies13.0%LARGE CAP PHARMA3 companies13.0%MED - BIOMED/GENE3 companies13.0%MEDICAL SERVICES3 companies13.0%MED - HMO2 companies8.7%MED/DENTAL - SUPP2 companies8.7%MED - HOSPITALS1 company4.3%ELEC COMP - SEMIC1 company4.3% David Toung's Ratings History at Argus Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsUNHUnitedHealth Group4/22/2026Upgrade$346.26$400.00Buy$0.0000.00% ROIIARTIntegra LifeSciences4/15/2026Reiterated Rating$11.06Hold$0.0000.00% ROIMDTMedtronic4/6/2026Lower Price Target$86.62$115.00Buy$0.0000.00% ROIBDXBecton, Dickinson and Company3/23/2026Lower Price Target$156.29$180.00Buy$0.0000.00% ROIPFEPfizer3/2/2026Upgrade$27.61$35.00Buy$0.0000.00% ROIHCAHCA Healthcare2/6/2026Boost Price Target$501.59$560.00Buy$0.0000.00% ROIJNJJohnson & Johnson1/23/2026Boost Price Target$220.29$240.00$0.0000.00% ROIHOLXHologic1/12/2026Downgrade$74.87Hold$0.0000.00% ROITECHBio-Techne11/20/2025Boost Price Target$57.81$68.00Buy$0.0000.00% ROITMOThermo Fisher Scientific10/29/2025Boost Price Target$570.59$610.00Buy$0.0000.00% ROIJNJJohnson & Johnson10/15/2025Set Price Target$190.63$210.00$0.0000.00% ROIHOLXHologic9/19/2025Boost Price Target$68.27$90.00Buy$0.0000.00% ROIMDTMedtronic8/26/2025Boost Price Target$92.05$115.00Buy$0.0000.00% ROIELVElevance Health7/21/2025Reiterated Rating$276.87Hold$0.0000.00% ROIGFSGlobalFoundries7/1/2025Initiated Coverage$38.20$52.00Buy$0.0000.00% ROITMOThermo Fisher Scientific4/29/2025Lower Price Target$426.24$470.00Buy$000.0000.00% ROIUNHUnitedHealth Group4/21/2025Downgrade$456.10Hold$000.0000.00% ROIIARTIntegra LifeSciences3/31/2025Upgrade$21.69Buy$0.0000.00% ROISYKStryker2/3/2025Set Price Target$382.59$450.00$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenRoyal Bank Of CanadaStifel NicolausBerenberg BankUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper Sandler Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
